Showing results (91-100 of 151) with videos related to
Sort By:
Pageof 16
The FEBS Journal|November 10, 2009
Oligomerized tumor necrosis factor-related apoptosis inducing ligand strongly induces cell death in myeloma cells, but also activates proinflammatory signaling pathwaysDaniela Berg, Thorsten Stühmer, Daniela Siegmund, et al.Frontiers in Immunology|August 7, 2023
Antibody-based soluble and membrane-bound TWEAK mimicking agonists with FcγR-independent activityOlena Zaitseva, Annett Hoffmann, Margaretha Löst, et al.Journal of Natural Products|October 24, 2019
A Near-Complete Series of Four Atropisomeric Jozimine A<sub>2</sub>-Type Naphthylisoquinoline Dimers with Antiplasmodial and Cytotoxic Activities and Related Alkaloids from <i>Ancistrocladus abbreviatus</i>Shaimaa Fayez, Jun Li, Doris Feineis, et al.Cell Death & Disease|January 21, 2025
TRAF2 and RIPK1 redundantly mediate classical NFκB signaling by TNFR1 and CD95-type death receptorsJennifer Wagner, David Vredevoogd, Xin Yu, et al.Journal of Molecular Medicine (Berlin, Germany)|April 1, 2010
TRAIL signaling is mediated by DR4 in pancreatic tumor cells despite the expression of functional DR5Johannes Lemke, Andreas Noack, Dieter Adam, et al.The Journal of Biological Chemistry|January 2, 2016
Binding Studies of TNF Receptor Superfamily (TNFRSF) Receptors on Intact CellsIsabell Lang, Simone Füllsack, Agnes Wyzgol, et al.Journal of Cell Science|June 22, 2002
Apoptotic crosstalk of TNF receptors: TNF-R2-induces depletion of TRAF2 and IAP proteins and accelerates TNF-R1-dependent activation of caspase-8Mariola Fotin-Mleczek, Frank Henkler, Dierk Samel, et al.Molecular and Cellular Biology|July 19, 2005
Death receptor-induced signaling pathways are differentially regulated by gamma interferon upstream of caspase 8 processingDaniela Siegmund, Andreas Wicovsky, Ingo Schmitz, et al.Cellular & Molecular Immunology|January 30, 2018
Stimulation of TNF receptor type 2 expands regulatory T cells and ameliorates established collagen-induced arthritis in miceVanessa Lamontain, Tobias Schmid, Dorothea Weber-Steffens, et al.Theranostics|February 24, 2022
CD40- and 41BB-specific antibody fusion proteins with PDL1 blockade-restricted agonismJuliane Medler, Kirstin Kucka, Vinicio Melo, et al.Pageof 16